ESC 365 - Plasma lysozyme as surrogate biomarker for detection of coronary artery disease in patients without Standard Modifiable Cardiovascular Risk Factors (SMuRFless)

ESC2025 Premium Access

Plasma lysozyme as surrogate biomarker for detection of coronary artery disease in patients without Standard Modifiable Cardiovascular Risk Factors (SMuRFless)

Session: Pathophysiology of ischaemic heart disease

Topic: Noninvasive Diagnostic Methods

Speaker: Doctor S. Fathieh (Buckinghamshire, GB)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Sina Fathieh

Wycombe Hospital, Buckinghamshire (United Kingdom of Great Britain & Northern Ireland)

0 follower

7 more presentations in this session

Unlocking the inflammatory 'code' in multivessel coronary disease: pathological network mediated by the PCSK9-NLRP3 axis and a novel microcirculatory dysfunction prediction model

Speaker: Professor C. Liu (Tianjin, CN)

Adipocytokines and risk of ischaemic events in acute coronary syndromes: an age-dependent relationship

Speaker: Doctor F. Bruno (Turin, IT)

Understanding the underpinning of hypertriglyceridemia as a risk factor for atherosclerosis

Speaker: Doctor M. Ferreira (Funchal, PT)

Xanthosine alleviates myocardial ischemia-reperfusion injury through attenuation of cardiomyocyte ferroptosis

Speaker: Doctor Y. Xu (Nanjing, CN)

Pathology of medial calcification in coronary arteries

Speaker: Doctor N. Nakamura (Isehara, JP)

Access the full session

Pathophysiology of ischaemic heart disease

Speakers: Doctor S. Fathieh, Professor C. Liu, Doctor F. Bruno, Doctor M. Ferreira, Doctor Y. Xu...

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources